Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma-Reference-Cited by-同舟云学术

Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma

Published:2005-09 Issue:3 Volume:98 Page:360-368
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Tewari Krishnansu S.,Mehta Rita S.,Burger Robert A.,Yu Ing-Ru,Kyshtoobayeva Ainura S.,Monk Bradley J.,Manetta Alberto,Berman Michael L.,Disaia Philip J.,Fruehauf John P.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference30 articles.

1. Recent advancements in the treatment of epithelial ovarian cancer;DiSaia;J. Obstet. Gynaecol. Res.,2001

2. Cancer statistics, 2005;Jemal;CA Cancer J. Clin.,2005

3. Cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N. Eng. J. Med.,1996

4. Treatment of refractory and recurrent ovarian cancer;Alberts;Semin. Oncol.,1999

5. Second-line treatment of ovarian cancer;Markman;Oncologist,2000

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABCC4 / MRP4 contributes to the aggressiveness of Myc‐associated epithelial ovarian cancer;International Journal of Cancer;2020-05-08

2. Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells;BMC Cancer;2020-04-03

3. Coiled-Coil and C2 Domain-Containing Protein 1A (CC2D1A) Promotes Chemotherapy Resistance in Ovarian Cancer;Frontiers in Oncology;2019-10-01

4. Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts;Molecular Cancer Therapeutics;2016-09-26

5. Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients;Current Pharmaceutical Design;2016-09-07